Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Comparative Effectiveness Study Assessing Treatment and Rates of Exacerbation Among Chronic Obstructive Pulmonary Disease Subjects in England

NCT03375450 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03375450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03375450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Comparative Effectiveness Study Assessing Treatment and Rates of Exacerbation Among Chronic Obstructive Pulmonary Disease Subjects in England
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 9, 2017
Completion date
August 30, 2019
Enrollment
60,243 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

comparative effectiveness study